Betulinic Acid Inhibits RANKL-Induced Osteoclastogenesis via Attenuating Akt, NF-κB, and PLCγ2-Ca2+ Signaling and Prevents Inflammatory Bone Loss
Authors:
- 2 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 83 (4) , 1174-1182
Abstract
The increase of bone-resorbing osteoclast activity in bone remodeling is the major characteristic of various bone diseases. Thus, inhibiting osteoclastogenesis and bone-resorbing function may be an effective therapeutic target for bone diseases. Betulinic acid (BA), a natural plant-derived pentacyclic triterpenoid compound, is known to possess numerous pharmacological and biochemical properties including anti-inflammatory, anticancer, and antiadipogenic activity. However, the effect of BA on osteoclast differentiation and function in bone metabolism has not been demonstrated so far. In this study, we investigated whether BA could suppress RANKL-induced osteoclastogenesis and bone resorption. Interestingly, BA significantly suppressed osteoclastogenesis by decreasing the phosphorylation of Akt and IκB, as well as PLCγ2-Ca2+ signaling, in pathways involved in early osteoclastogenesis as well as through the subsequent suppression of c-Fos and NFATc1. The inhibition of these pathways by BA was once more confirmed by retrovirus infection of constitutively active (CA)-Akt and CA-Ikkβ retrovirus and measurement of Ca2+ influx. BA also significantly inhibited the expression of osteoclastogenesis-specific marker genes. Moreover, we found that BA administration restored the bone loss induced through acute lipopolysaccharide injection in mice by a micro-CT and histological analysis. Our findings suggest that BA is a potential therapeutic candidate for bone diseases involving osteoclasts.Keywords
Funding Information
- Wonkwang University
This publication has 36 references indexed in Scilit:
- Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factorsBMC Cancer, 2011
- Calcium signaling in osteoclastsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Cellular mechanisms of bone remodelingReviews in Endocrine and Metabolic Disorders, 2010
- Betulinic Acid, a Natural Pentacyclic Triterpenoid, Prevents Abdominal Fat Accumulation in Mice Fed a High-Fat DietJournal of Agricultural and Food Chemistry, 2009
- The Osteoclast: Friend or Foe?Annual Review of Pathology: Mechanisms of Disease, 2008
- Akt1 in Osteoblasts and Osteoclasts Controls Bone RemodelingPLOS ONE, 2007
- PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2Journal of Clinical Investigation, 2006
- Betulinic acid induces apoptosis in skin cancer cells and differentiation in normal human keratinocytesExperimental Dermatology, 2005
- Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2Genes & Development, 2003
- Osteoclast differentiation and activationNature, 2003